Newer HCV Drugs Reduce Mortality, Liver Cancer Risk Newer HCV Drugs Reduce Mortality, Liver Cancer Risk
Treatment with direct-acting antivirals appears to reduce the risk of death and liver cancer among patients with chronic hepatitis C virus (HCV), including those with cirrhosis, new data has shown.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Cirrhosis | Health | Hematology | Hepatitis | Hepatitis C | Liver | Urology & Nephrology